$1.5 million in grants will study urgency urinary incontinence

Urogynecology experts will evaluate using Botox® to treat a variety of UUI over a spectrum of ages.
Written by: Shawna Masters
Media contact: Hannah Echols

Stream Richter and MeyerHolly E. Richter, M.D., Ph.D. and Isuzu Meyer, M.D.Researchers at the University of Alabama at Birmingham have been awarded two grants from the Patient-Centered Outcomes Research Institute for more than $1.5 million. The grants will fund two studies that focus on urgency urinary incontinence in women.

Holly E. Richter, M.D., Ph.D., professor, and Isuzu Meyer, M.D., associate professor in the UAB Department of Obstetrics and Gynecology Division of Urogynecology and Pelvic Reconstructive Surgery, are principal investigators of the studies. Both studies will evaluate onabotulinumtoxinA, or Botox®, as a treatment of a variety of UUI.

“Women are living longer and wish to maintain and improve their activities and quality of life,” Richter said. “These two studies will provide important information toward the understanding of effective treatment of UUI over a spectrum of ages.” 

“Women in the community have been actively engaged during trial design and will remain active during the course of these studies,” Meyer said.

For more information regarding the trials, interested patients can visit division website or call 205-934-5498.